| Date Filed | Type | Description |
| 08/10/2023 |
4
| Lamothe Jeffrey G. (EVP, COO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 11,979 restricted stock units
@ $0
Exercised 1,833 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| Lamothe Jeffrey G. (EVP, COO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 3,666 restricted stock units
@ $0
Granted 16,500 restricted stock units
@ $0
Granted 16,500 options to buy
@ $2.15, valued at
$35.5k
|
|
| 01/30/2023 |
4
| Lamothe Jeffrey G. (CFO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 1,834 restricted stock units
@ $0 |
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Lamothe Jeffrey G. (SVP and CFO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 1,833 restricted stock units
@ $0 |
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2019 |
4
| Lamothe Jeffrey G. (SVP, CFO and Treasurer) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 135,384 options to buy
@ $0.576, valued at
$78k
|
|
| 03/04/2019 |
4
| Lamothe Jeffrey G. (SVP and CFO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 2,170 shares
@ $1.57, valued at
$3.4k
Granted 67,400 options to buy
@ $1.52, valued at
$102.4k
Exercised 7,318 restricted stock units
@ $0 |
|
| 03/13/2018 |
4
| Lamothe Jeffrey G. (SVP, CFO and Treasurer) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 1,583 shares
@ $3.13, valued at
$5k
Granted 67,400 options to buy
@ $3.13, valued at
$211k
Exercised 6,747 restricted stock units
@ $0 |
|
| 03/05/2018 |
4
| Lamothe Jeffrey G. (SVP, CFO and Treasurer) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 1,717 shares
@ $3.04, valued at
$5.2k
Exercised 7,320 restricted stock units
@ $0 |
|
| 02/06/2018 |
4
| Lamothe Jeffrey G. (SVP, CFO and Treasurer) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 7,514 shares
@ $3.24, valued at
$24.3k
Exercised 25,340 restricted stock units
@ $0 |
|
| 06/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/27/2016 |
4/A
| Lamothe Jeffrey G. (SVP, CFO and Treasurer) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 50,680 restricted stock units
@ $0 |
|
| 08/05/2016 |
4
| Lamothe Jeffrey G. (SVP, CFO and Treasurer) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 50,680 restricted stock units
@ $0 |
|
| 08/02/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |